Agilent Fragment Analyzer (96 capillary) and Femto pulse instruments

Closed Pre-Solicitation Posted

Solicitation number
2026-95438
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Atlanta, Georgia 30329, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention (CDC), operating under the Department of Health and Human Services Office of Acquisition Services, intends to procure preventative and remedial maintenance services for Agilent Fragment Analyzer (96 capillary) and Femto pulse instruments operated within the Biotechnology Core Facility Branch. This sole source firm fixed price maintenance contract is intended to comply with the requirements of the Quality Management System and will include software and maintenance service agreement support. The CDC intends to award this contract to Agilent Technologies under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1), though interested vendors may submit responses demonstrating their interest and capability. While this is not a competitive solicitation, all quotations and responses received by the deadline will be considered by the government in determining whether to conduct a competitive procurement. Interested parties must submit their responses via email to the Contracting Officer at uex0@cdc.gov by 5:00 PM Eastern Time on December 31, 2025.

This procurement carries no set-aside designation and Agilent Technologies appears to be the identified incumbent vendor for these specialized instruments. The contract period of performance runs from February 2, 2026, through February 1, 2027, with two one-year option periods available, providing up to three years of potential contract duration. No specific award value or budget range is disclosed in this pre-solicitation notice. The requirement falls under NAICS Code 541714 (Research and Development in Biotechnology) and PSC Code J066 (Maintenance/Repair/Rebuild of Equipment—Instruments and Laboratory Equipment), indicating this is technical maintenance support for laboratory instruments used in biotechnology research applications.

Notice text

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price maintenance contract to Agilent Technologies for the preventative and remedial maintenance of the Agilent Fragment Analyzer (96 capillary) and Femto pulse instruments operated within the Biotechnology Core Facility Branch (BCFB) to comply with the requirements of the Quality Management System (QMS). The anticipated period of performance is 02/02/2026 through 2/01/2027 and will include two one-year option periods.

This contract action is for software and maintenance service agreement support service for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested vendors may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received prior to the date and time below will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to the Contracting Officer at uex0@cdc.gov by 5:00PM (ET) on 12/31/2025.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity